Working with Bohr

Almost since I can remember, my ambition was to be a physicist. My parents had both studied physics and worked for a short time in the Cavendish Laboratory, and, although neither made a career in science, I was brought up knowing about physics. At both preparatory and secondary schools, however, my most inspiring teachers taught mathematics, and I left school with a maths scholarship to Cambridge and the ambition to work on quantum theory. That was in 1923, when Sommerfeld and others were still

Written byNevill Mott
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Almost since I can remember, my ambition was to be a physicist. My parents had both studied physics and worked for a short time in the Cavendish Laboratory, and, although neither made a career in science, I was brought up knowing about physics. At both preparatory and secondary schools, however, my most inspiring teachers taught mathematics, and I left school with a maths scholarship to Cambridge and the ambition to work on quantum theory. That was in 1923, when Sommerfeld and others were still elaborating Niels Bohr's theory of orbits.

But in 1926, when I took my final examination-which included some questions on quantum theory-the "new" quantum mechanics of Heisenberg and Schrodinger appeared and everything was changed. Bohr's orbits were dead. Most of physics and all of chemistry were now open to the theorist, once he or she could understand the new theory.

But there was no one in Cambridge ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas